Literature DB >> 22732750

Atypical femoral fracture risk in patients treated with bisphosphonates.

Douglas C Bauer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22732750      PMCID： PMC4014073          DOI： 10.1001/archinternmed.2012.1827

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  9 in total

1.  Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Authors:  Dennis M Black; Michael P Kelly; Harry K Genant; Lisa Palermo; Richard Eastell; Christina Bucci-Rechtweg; Jane Cauley; Ping Chung Leung; Steven Boonen; Arthur Santora; Anne de Papp; Douglas C Bauer
Journal:  N Engl J Med       Date:  2010-03-24       Impact factor: 91.245

2.  Severely suppressed bone turnover: a potential complication of alendronate therapy.

Authors:  Clarita V Odvina; Joseph E Zerwekh; D Sudhaker Rao; Naim Maalouf; Frank A Gottschalk; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

3.  Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.

Authors:  Raphael P H Meier; Thomas V Perneger; Richard Stern; René Rizzoli; Robin E Peter
Journal:  Arch Intern Med       Date:  2012-06-25

4.  Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

Authors:  Dennis M Black; Ann V Schwartz; Kristine E Ensrud; Jane A Cauley; Silvina Levis; Sara A Quandt; Suzanne Satterfield; Robert B Wallace; Douglas C Bauer; Lisa Palermo; Lois E Wehren; Antonio Lombardi; Arthur C Santora; Steven R Cummings
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

5.  Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.

Authors:  Bo Abrahamsen; Pia Eiken; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

6.  Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

7.  Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

Authors:  S-K Goh; K Y Yang; J S B Koh; M K Wong; S Y Chua; D T C Chua; T S Howe
Journal:  J Bone Joint Surg Br       Date:  2007-03

8.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

9.  The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT).

Authors:  Dennis M Black; Ian R Reid; Steven Boonen; Christina Bucci-Rechtweg; Jane A Cauley; Felicia Cosman; Steven R Cummings; Trisha F Hue; Kurt Lippuner; Peter Lakatos; Ping Chung Leung; Zulema Man; Ruvie Lou Maria Martinez; Monique Tan; Mary Ellen Ruzycky; Guoqin Su; Richard Eastell
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741
  9 in total
  3 in total

1.  Atypical femoral fractures associated with long-term bisphosphonate use.

Authors:  Soumya Chatterjee
Journal:  CMAJ       Date:  2013-05-06       Impact factor: 8.262

2.  Successful conservative treatment: multiple atypical fractures in osteoporotic patients after bisphosphate medication: a unique case report.

Authors:  Hyo-Sang Kim; Han Young Jung; Myeong-Ok Kim; Kyung-Lim Joa; Yeo Ju Kim; Su-Yeon Kwon; Chang-Hwan Kim
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

3.  Histology of 8 atypical femoral fractures: remodeling but no healing.

Authors:  Jörg Schilcher; Olof Sandberg; Hanna Isaksson; Per Aspenberg
Journal:  Acta Orthop       Date:  2014-04-30       Impact factor: 3.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.